Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy

Crohn's disease (CD) is chronic inflammatory bowel disease with different phenotypic characteristics influencing disease prognosis and therapeutic strategies. The aim of this pilot study was to analyze selected inflammatory and apoptotic markers in non-inflamed and inflamed samples of ileal muc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology, research and practice research and practice, 2020-06, Vol.216 (6), p.152945-152945, Article 152945
Hauptverfasser: Stankovic, Biljana, Dragasevic, Sanja, Klaassen, Kristel, Kotur, Nikola, Srzentic Drazilov, Sanja, Zukic, Branka, Sokic Milutinovic, Aleksandra, Milovanovic, Tamara, Lukic, Snezana, Popovic, Dragan, Pavlovic, Sonja, Nikcevic, Gordana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 152945
container_issue 6
container_start_page 152945
container_title Pathology, research and practice
container_volume 216
creator Stankovic, Biljana
Dragasevic, Sanja
Klaassen, Kristel
Kotur, Nikola
Srzentic Drazilov, Sanja
Zukic, Branka
Sokic Milutinovic, Aleksandra
Milovanovic, Tamara
Lukic, Snezana
Popovic, Dragan
Pavlovic, Sonja
Nikcevic, Gordana
description Crohn's disease (CD) is chronic inflammatory bowel disease with different phenotypic characteristics influencing disease prognosis and therapeutic strategies. The aim of this pilot study was to analyze selected inflammatory and apoptotic markers in non-inflamed and inflamed samples of ileal mucosa of non-stricturing/non-penetrating (NS/NP) and stricturing (S) CD mucosal phenotypes in order to characterize their distinct profiles. From twenty CD patients (9 NS/NP, 11 S) paired non-inflamed and inflamed ileal biopsies were collected and used for analysis of cytokine (TNF and IL6) and apoptotic (Bcl2, Bax, Fas and FasL) genes' expression levels by real-time PCR, while NFκB transcriptional potency was assessed by electromobility gel shift assay. Our results demonstrated significant upregulation of TNF and IL6 in inflamed area of both NS/NP (p = 0.03, p = 0.01) and S phenotypes (p = 0.04, p = 0.04), respectively. However, TNF increase was more prominent in NS/NP compared to S inflamed mucosa (p = 0.02). Also, level of proapoptotic Bax was significantly higher in NS/NP compared to S inflamed mucosa (p = 0.01). Opposing transcription potency of NFκB has been detected between two phenotypes: being decreased in NS/NP (p = 0.07) and increased in S (p = 0.1) inflamed compared to non-inflamed mucosa, demonstrating trend towards statistical significance. We found that two distinct CD phenotypes have specific molecular signatures. Obtained results could direct improvement of current and development of new therapeutic strategies based on more specific molecular stratification of CD patients.
doi_str_mv 10.1016/j.prp.2020.152945
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2389211535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0344033819328973</els_id><sourcerecordid>2389211535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-e2a4dc720da3d54f7be65c3bd62892e7807963e285ae8acf2400ec1dde21d2e03</originalsourceid><addsrcrecordid>eNp9UcuOEzEQtBCIDYEP4IJ8g8sEP-YVOK2iXUBaiQuIo9WxexJHM7axPQvzMfwrDlk4cumXqqvUXYS85GzDGW_fnjYhho1govSN2NbNI7LiLe8r1kr-mKyYrOuKSdlfkWcpnRhjHav5U3Ilhei2W96vyK-bn2H00boDtW4YYZog-7hQcIZC8CH7bDVN9uAgzxFTQVFjU7ZOZ7qL_uhep_MAISENR3Q-LwHTO_oNFpr9D4gm0cmPqOcRIk05QraD1SV6R_1AQ6nQ5fRHMUM8YMZSHDFCWJ6TJwOMCV885DX5envzZfexuvv84dPu-q7SspG5QgG10Z1gBqRp6qHbY9touTet6LcCu55121ai6BvAHvQgasZQc2NQcCOQyTV5c-EN0X-fMWU12aRxHMGhn5MSsvBw3hS1NeEXqI4-pYiDCtFOEBfFmTq7ok5lEtTZFXVxpey8eqCf9xOafxt_bSiA9xcAliPvLUaVdPmKRmMj6qyMt_-h_w2d7qJZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2389211535</pqid></control><display><type>article</type><title>Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Stankovic, Biljana ; Dragasevic, Sanja ; Klaassen, Kristel ; Kotur, Nikola ; Srzentic Drazilov, Sanja ; Zukic, Branka ; Sokic Milutinovic, Aleksandra ; Milovanovic, Tamara ; Lukic, Snezana ; Popovic, Dragan ; Pavlovic, Sonja ; Nikcevic, Gordana</creator><creatorcontrib>Stankovic, Biljana ; Dragasevic, Sanja ; Klaassen, Kristel ; Kotur, Nikola ; Srzentic Drazilov, Sanja ; Zukic, Branka ; Sokic Milutinovic, Aleksandra ; Milovanovic, Tamara ; Lukic, Snezana ; Popovic, Dragan ; Pavlovic, Sonja ; Nikcevic, Gordana</creatorcontrib><description>Crohn's disease (CD) is chronic inflammatory bowel disease with different phenotypic characteristics influencing disease prognosis and therapeutic strategies. The aim of this pilot study was to analyze selected inflammatory and apoptotic markers in non-inflamed and inflamed samples of ileal mucosa of non-stricturing/non-penetrating (NS/NP) and stricturing (S) CD mucosal phenotypes in order to characterize their distinct profiles. From twenty CD patients (9 NS/NP, 11 S) paired non-inflamed and inflamed ileal biopsies were collected and used for analysis of cytokine (TNF and IL6) and apoptotic (Bcl2, Bax, Fas and FasL) genes' expression levels by real-time PCR, while NFκB transcriptional potency was assessed by electromobility gel shift assay. Our results demonstrated significant upregulation of TNF and IL6 in inflamed area of both NS/NP (p = 0.03, p = 0.01) and S phenotypes (p = 0.04, p = 0.04), respectively. However, TNF increase was more prominent in NS/NP compared to S inflamed mucosa (p = 0.02). Also, level of proapoptotic Bax was significantly higher in NS/NP compared to S inflamed mucosa (p = 0.01). Opposing transcription potency of NFκB has been detected between two phenotypes: being decreased in NS/NP (p = 0.07) and increased in S (p = 0.1) inflamed compared to non-inflamed mucosa, demonstrating trend towards statistical significance. We found that two distinct CD phenotypes have specific molecular signatures. Obtained results could direct improvement of current and development of new therapeutic strategies based on more specific molecular stratification of CD patients.</description><identifier>ISSN: 0344-0338</identifier><identifier>EISSN: 1618-0631</identifier><identifier>DOI: 10.1016/j.prp.2020.152945</identifier><identifier>PMID: 32279918</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Adult ; Apoptosis - genetics ; Crohn Disease - pathology ; Cytokines - genetics ; Female ; Humans ; Ileal Crohn's disease ; Inflammation - genetics ; Inflammation - pathology ; Intestinal Mucosa - pathology ; Male ; Middle Aged ; Molecular profiling ; Molecular Targeted Therapy ; Mucosal phenotypes ; Phenotype ; Pilot Projects ; Transcriptome ; Young Adult</subject><ispartof>Pathology, research and practice, 2020-06, Vol.216 (6), p.152945-152945, Article 152945</ispartof><rights>2020 Elsevier GmbH</rights><rights>Copyright © 2020 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-e2a4dc720da3d54f7be65c3bd62892e7807963e285ae8acf2400ec1dde21d2e03</citedby><cites>FETCH-LOGICAL-c353t-e2a4dc720da3d54f7be65c3bd62892e7807963e285ae8acf2400ec1dde21d2e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0344033819328973$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32279918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stankovic, Biljana</creatorcontrib><creatorcontrib>Dragasevic, Sanja</creatorcontrib><creatorcontrib>Klaassen, Kristel</creatorcontrib><creatorcontrib>Kotur, Nikola</creatorcontrib><creatorcontrib>Srzentic Drazilov, Sanja</creatorcontrib><creatorcontrib>Zukic, Branka</creatorcontrib><creatorcontrib>Sokic Milutinovic, Aleksandra</creatorcontrib><creatorcontrib>Milovanovic, Tamara</creatorcontrib><creatorcontrib>Lukic, Snezana</creatorcontrib><creatorcontrib>Popovic, Dragan</creatorcontrib><creatorcontrib>Pavlovic, Sonja</creatorcontrib><creatorcontrib>Nikcevic, Gordana</creatorcontrib><title>Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy</title><title>Pathology, research and practice</title><addtitle>Pathol Res Pract</addtitle><description>Crohn's disease (CD) is chronic inflammatory bowel disease with different phenotypic characteristics influencing disease prognosis and therapeutic strategies. The aim of this pilot study was to analyze selected inflammatory and apoptotic markers in non-inflamed and inflamed samples of ileal mucosa of non-stricturing/non-penetrating (NS/NP) and stricturing (S) CD mucosal phenotypes in order to characterize their distinct profiles. From twenty CD patients (9 NS/NP, 11 S) paired non-inflamed and inflamed ileal biopsies were collected and used for analysis of cytokine (TNF and IL6) and apoptotic (Bcl2, Bax, Fas and FasL) genes' expression levels by real-time PCR, while NFκB transcriptional potency was assessed by electromobility gel shift assay. Our results demonstrated significant upregulation of TNF and IL6 in inflamed area of both NS/NP (p = 0.03, p = 0.01) and S phenotypes (p = 0.04, p = 0.04), respectively. However, TNF increase was more prominent in NS/NP compared to S inflamed mucosa (p = 0.02). Also, level of proapoptotic Bax was significantly higher in NS/NP compared to S inflamed mucosa (p = 0.01). Opposing transcription potency of NFκB has been detected between two phenotypes: being decreased in NS/NP (p = 0.07) and increased in S (p = 0.1) inflamed compared to non-inflamed mucosa, demonstrating trend towards statistical significance. We found that two distinct CD phenotypes have specific molecular signatures. Obtained results could direct improvement of current and development of new therapeutic strategies based on more specific molecular stratification of CD patients.</description><subject>Adult</subject><subject>Apoptosis - genetics</subject><subject>Crohn Disease - pathology</subject><subject>Cytokines - genetics</subject><subject>Female</subject><subject>Humans</subject><subject>Ileal Crohn's disease</subject><subject>Inflammation - genetics</subject><subject>Inflammation - pathology</subject><subject>Intestinal Mucosa - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular profiling</subject><subject>Molecular Targeted Therapy</subject><subject>Mucosal phenotypes</subject><subject>Phenotype</subject><subject>Pilot Projects</subject><subject>Transcriptome</subject><subject>Young Adult</subject><issn>0344-0338</issn><issn>1618-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcuOEzEQtBCIDYEP4IJ8g8sEP-YVOK2iXUBaiQuIo9WxexJHM7axPQvzMfwrDlk4cumXqqvUXYS85GzDGW_fnjYhho1govSN2NbNI7LiLe8r1kr-mKyYrOuKSdlfkWcpnRhjHav5U3Ilhei2W96vyK-bn2H00boDtW4YYZog-7hQcIZC8CH7bDVN9uAgzxFTQVFjU7ZOZ7qL_uhep_MAISENR3Q-LwHTO_oNFpr9D4gm0cmPqOcRIk05QraD1SV6R_1AQ6nQ5fRHMUM8YMZSHDFCWJ6TJwOMCV885DX5envzZfexuvv84dPu-q7SspG5QgG10Z1gBqRp6qHbY9touTet6LcCu55121ai6BvAHvQgasZQc2NQcCOQyTV5c-EN0X-fMWU12aRxHMGhn5MSsvBw3hS1NeEXqI4-pYiDCtFOEBfFmTq7ok5lEtTZFXVxpey8eqCf9xOafxt_bSiA9xcAliPvLUaVdPmKRmMj6qyMt_-h_w2d7qJZ</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Stankovic, Biljana</creator><creator>Dragasevic, Sanja</creator><creator>Klaassen, Kristel</creator><creator>Kotur, Nikola</creator><creator>Srzentic Drazilov, Sanja</creator><creator>Zukic, Branka</creator><creator>Sokic Milutinovic, Aleksandra</creator><creator>Milovanovic, Tamara</creator><creator>Lukic, Snezana</creator><creator>Popovic, Dragan</creator><creator>Pavlovic, Sonja</creator><creator>Nikcevic, Gordana</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202006</creationdate><title>Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy</title><author>Stankovic, Biljana ; Dragasevic, Sanja ; Klaassen, Kristel ; Kotur, Nikola ; Srzentic Drazilov, Sanja ; Zukic, Branka ; Sokic Milutinovic, Aleksandra ; Milovanovic, Tamara ; Lukic, Snezana ; Popovic, Dragan ; Pavlovic, Sonja ; Nikcevic, Gordana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-e2a4dc720da3d54f7be65c3bd62892e7807963e285ae8acf2400ec1dde21d2e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Apoptosis - genetics</topic><topic>Crohn Disease - pathology</topic><topic>Cytokines - genetics</topic><topic>Female</topic><topic>Humans</topic><topic>Ileal Crohn's disease</topic><topic>Inflammation - genetics</topic><topic>Inflammation - pathology</topic><topic>Intestinal Mucosa - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular profiling</topic><topic>Molecular Targeted Therapy</topic><topic>Mucosal phenotypes</topic><topic>Phenotype</topic><topic>Pilot Projects</topic><topic>Transcriptome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stankovic, Biljana</creatorcontrib><creatorcontrib>Dragasevic, Sanja</creatorcontrib><creatorcontrib>Klaassen, Kristel</creatorcontrib><creatorcontrib>Kotur, Nikola</creatorcontrib><creatorcontrib>Srzentic Drazilov, Sanja</creatorcontrib><creatorcontrib>Zukic, Branka</creatorcontrib><creatorcontrib>Sokic Milutinovic, Aleksandra</creatorcontrib><creatorcontrib>Milovanovic, Tamara</creatorcontrib><creatorcontrib>Lukic, Snezana</creatorcontrib><creatorcontrib>Popovic, Dragan</creatorcontrib><creatorcontrib>Pavlovic, Sonja</creatorcontrib><creatorcontrib>Nikcevic, Gordana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology, research and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stankovic, Biljana</au><au>Dragasevic, Sanja</au><au>Klaassen, Kristel</au><au>Kotur, Nikola</au><au>Srzentic Drazilov, Sanja</au><au>Zukic, Branka</au><au>Sokic Milutinovic, Aleksandra</au><au>Milovanovic, Tamara</au><au>Lukic, Snezana</au><au>Popovic, Dragan</au><au>Pavlovic, Sonja</au><au>Nikcevic, Gordana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy</atitle><jtitle>Pathology, research and practice</jtitle><addtitle>Pathol Res Pract</addtitle><date>2020-06</date><risdate>2020</risdate><volume>216</volume><issue>6</issue><spage>152945</spage><epage>152945</epage><pages>152945-152945</pages><artnum>152945</artnum><issn>0344-0338</issn><eissn>1618-0631</eissn><abstract>Crohn's disease (CD) is chronic inflammatory bowel disease with different phenotypic characteristics influencing disease prognosis and therapeutic strategies. The aim of this pilot study was to analyze selected inflammatory and apoptotic markers in non-inflamed and inflamed samples of ileal mucosa of non-stricturing/non-penetrating (NS/NP) and stricturing (S) CD mucosal phenotypes in order to characterize their distinct profiles. From twenty CD patients (9 NS/NP, 11 S) paired non-inflamed and inflamed ileal biopsies were collected and used for analysis of cytokine (TNF and IL6) and apoptotic (Bcl2, Bax, Fas and FasL) genes' expression levels by real-time PCR, while NFκB transcriptional potency was assessed by electromobility gel shift assay. Our results demonstrated significant upregulation of TNF and IL6 in inflamed area of both NS/NP (p = 0.03, p = 0.01) and S phenotypes (p = 0.04, p = 0.04), respectively. However, TNF increase was more prominent in NS/NP compared to S inflamed mucosa (p = 0.02). Also, level of proapoptotic Bax was significantly higher in NS/NP compared to S inflamed mucosa (p = 0.01). Opposing transcription potency of NFκB has been detected between two phenotypes: being decreased in NS/NP (p = 0.07) and increased in S (p = 0.1) inflamed compared to non-inflamed mucosa, demonstrating trend towards statistical significance. We found that two distinct CD phenotypes have specific molecular signatures. Obtained results could direct improvement of current and development of new therapeutic strategies based on more specific molecular stratification of CD patients.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>32279918</pmid><doi>10.1016/j.prp.2020.152945</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0344-0338
ispartof Pathology, research and practice, 2020-06, Vol.216 (6), p.152945-152945, Article 152945
issn 0344-0338
1618-0631
language eng
recordid cdi_proquest_miscellaneous_2389211535
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Apoptosis - genetics
Crohn Disease - pathology
Cytokines - genetics
Female
Humans
Ileal Crohn's disease
Inflammation - genetics
Inflammation - pathology
Intestinal Mucosa - pathology
Male
Middle Aged
Molecular profiling
Molecular Targeted Therapy
Mucosal phenotypes
Phenotype
Pilot Projects
Transcriptome
Young Adult
title Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A17%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploring%20inflammatory%20and%20apoptotic%20signatures%20in%20distinct%20Crohn's%20disease%20phenotypes:%20Way%20towards%20molecular%20stratification%20of%20patients%20and%20targeted%20therapy&rft.jtitle=Pathology,%20research%20and%20practice&rft.au=Stankovic,%20Biljana&rft.date=2020-06&rft.volume=216&rft.issue=6&rft.spage=152945&rft.epage=152945&rft.pages=152945-152945&rft.artnum=152945&rft.issn=0344-0338&rft.eissn=1618-0631&rft_id=info:doi/10.1016/j.prp.2020.152945&rft_dat=%3Cproquest_cross%3E2389211535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2389211535&rft_id=info:pmid/32279918&rft_els_id=S0344033819328973&rfr_iscdi=true